Shares of Blueprint Medicines (BPMC) have gained 2.7% over the past four weeks to close the last trading session at $88.65, but there could still be a solid upside left in the stock if short-term ...

Selling the news is a common trading strategy in which traders buy a stock in anticipation of expected news, then sell once ...

Aperam S.A. faces challenges amid a cyclical downturn in the steel sector. Click here to see why APEMY stock is a Buy.

CAMP4 Therapeutics (NASDAQ:CAMP) priced its IPO of 6.82M shares at an initial public offering price of $11.00 per share. The gross proceeds are expected to be ~$75M. CAMP4’s common stock is expected ...

Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 Therapeutics this morning in becoming the latest ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

ANI Pharmaceuticals acquired Alimera Sciences, boosting its rare disease segment with a couple of durable ophthalmology ...

Boston-area biotechs Upstream Bio and CAMP4 Therapeutics are headed to the Nasdaq on Friday, the latest companies to IPO in ...